INTERNATIONAL PATENT: HANMI PHARM. CO., LTD., 한미약품 주식회사 FILES APPLICATION FOR "ORALLY DISINTEGRATING TABLET COMPRISING PREGABALIN OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF"

GENEVA, Dec. 23 -- HANMI PHARM. CO., LTD. (214, Muha-ro, Paltan-myeon,Hwaseong-si,Gyeonggi-do 18536), 한미약품 주식회사 (경기도화성시팔탄면 무하로 214) filed a patent application (PCT/KR2025/008123) for "ORALLY DISINTEGRATING TABLET COMPRISING PREGABALIN OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF" on Jun 13, 2025. With publication no. WO/2025/259048, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KIM, ...